Efficacy and Safety Study of ATG for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of combined ATG
（antithymocyte globulin ） regimen for aGVHD(acute graft-versus-host disease ) prophylaxis in
matched sibling donor peripheral blood stem cell transplantation (MSD-PBSCT).
Phase:
Phase 4
Details
Lead Sponsor:
Chinese PLA General Hospital
Collaborators:
309th Hospital of Chinese People's Liberation Army Beijing Naval General Hospital Space Center Hospital, Peking University